Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP244445.RAUmfunJfftlWyXCUWa5A42-TabdmHa0Y5L6tvGBahISE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP244445.RAUmfunJfftlWyXCUWa5A42-TabdmHa0Y5L6tvGBahISE130_assertion type Assertion NP244445.RAUmfunJfftlWyXCUWa5A42-TabdmHa0Y5L6tvGBahISE130_head.
- NP244445.RAUmfunJfftlWyXCUWa5A42-TabdmHa0Y5L6tvGBahISE130_assertion wasGeneratedBy ECO_0000203 NP244445.RAUmfunJfftlWyXCUWa5A42-TabdmHa0Y5L6tvGBahISE130_provenance.
- NP244445.RAUmfunJfftlWyXCUWa5A42-TabdmHa0Y5L6tvGBahISE130_assertion wasDerivedFrom befree-20150227 NP244445.RAUmfunJfftlWyXCUWa5A42-TabdmHa0Y5L6tvGBahISE130_provenance.
- NP244445.RAUmfunJfftlWyXCUWa5A42-TabdmHa0Y5L6tvGBahISE130_assertion SIO_000772 22236405 NP244445.RAUmfunJfftlWyXCUWa5A42-TabdmHa0Y5L6tvGBahISE130_provenance.
- NP244445.RAUmfunJfftlWyXCUWa5A42-TabdmHa0Y5L6tvGBahISE130_assertion evidence source_evidence_literature NP244445.RAUmfunJfftlWyXCUWa5A42-TabdmHa0Y5L6tvGBahISE130_provenance.
- NP244445.RAUmfunJfftlWyXCUWa5A42-TabdmHa0Y5L6tvGBahISE130_assertion description "[Mixed dyslipidemia, characterized by elevated triglyceride and apoC-III levels and low HDL cholesterol level, with or without elevated LDL cholesterol, increases cardiovascular disease risk and is commonly treated with combined statin and fibrate therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP244445.RAUmfunJfftlWyXCUWa5A42-TabdmHa0Y5L6tvGBahISE130_provenance.